EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade

Anand Narayanan, Friedrich D Knollmann, Julie Ann S. Walby, Steffany Lim, David R Gandara, Jonathan Riess

Research output: Contribution to journal › Article

2 Citations (Scopus)
Original languageEnglish (US)
JournalClinical Lung Cancer
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Human Herpesvirus 4
Immunotherapy
Carcinoma
Lung
MPDL3280A

Keywords

  • Atezolizumab
  • EBV-positive malignancy
  • Immunotherapy
  • PD-L1 antibody
  • Pulmonary lymphoepithelioma-like carcinoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade. / Narayanan, Anand; Knollmann, Friedrich D; Walby, Julie Ann S.; Lim, Steffany; Gandara, David R; Riess, Jonathan.

In: Clinical Lung Cancer, 01.01.2019.

Research output: Contribution to journal › Article

Narayanan, A, Knollmann, FD, Walby, JAS, Lim, S, Gandara, DR & Riess, J 2019, 'EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade', Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2018.12.015
Narayanan A, Knollmann FD, Walby JAS, Lim S, Gandara DR, Riess J. EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade. Clinical Lung Cancer. 2019 Jan 1. https://doi.org/10.1016/j.cllc.2018.12.015
Narayanan, Anand ; Knollmann, Friedrich D ; Walby, Julie Ann S. ; Lim, Steffany ; Gandara, David R ; Riess, Jonathan. / EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade. In: Clinical Lung Cancer. 2019.
@article{2103e50104b745e3800783a46fb75d5c,
title = "EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade",
keywords = "Atezolizumab, EBV-positive malignancy, Immunotherapy, PD-L1 antibody, Pulmonary lymphoepithelioma-like carcinoma",
author = "Anand Narayanan and Knollmann, {Friedrich D} and Walby, {Julie Ann S.} and Steffany Lim and Gandara, {David R} and Jonathan Riess",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cllc.2018.12.015",
language = "English (US)",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",

}

TY - JOUR

T1 - EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade

AU - Narayanan, Anand

AU - Knollmann, Friedrich D

AU - Walby, Julie Ann S.

AU - Lim, Steffany

AU - Gandara, David R

AU - Riess, Jonathan

PY - 2019/1/1

Y1 - 2019/1/1

KW - Atezolizumab

KW - EBV-positive malignancy

KW - Immunotherapy

KW - PD-L1 antibody

KW - Pulmonary lymphoepithelioma-like carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85060173550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060173550&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2018.12.015

DO - 10.1016/j.cllc.2018.12.015

M3 - Article

C2 - 30679078

AN - SCOPUS:85060173550

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

ER -

Access to Document